CVS Health Corp. (CVS)

64.28
0.65 1.00
NYSE : Retail Trade
Prev Close 63.63
Open 64.18
Day Low/High 64.01 / 64.69
52 Wk Low/High 51.72 / 82.15
Volume 10.38M
Avg Volume 8.00M
Exchange NYSE
Shares Outstanding 1.30B
Market Cap 82.27B
EPS -0.60
P/E Ratio 17.88
Div & Yield 2.00 (3.15%)

Latest News

Miami Heat's Bam Adebayo Helps CVS Health Kick Off Free Health Screenings In Miami

Miami Heat's Bam Adebayo Helps CVS Health Kick Off Free Health Screenings In Miami

48 Project Health events help to eliminate barriers to access, affordability and quality care

The Best Stocks Are Never Cheap: Cramer's 'Mad Money' Recap (Thursday 9/19/19)

The Best Stocks Are Never Cheap: Cramer's 'Mad Money' Recap (Thursday 9/19/19)

Once in a while, says Jim Cramer, there are meaningful pullbacks in high-quality stocks. And investors need to be ready to buy.

CVS Health Offering Nearly 600 Free Wellness Screening Events In 12 Markets Across U.S

CVS Health Offering Nearly 600 Free Wellness Screening Events In 12 Markets Across U.S

Annual Project Health events at CVS Pharmacy locations have delivered more than $127 million worth of free health services since 2006

Markets Have a Strong Week on Sector Rotation, Reviving Chip Stocks

Easing trade tensions and steepening yield curve add to bulls' optimism.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CVS Health Corporation - CVS

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CVS Health Corporation - CVS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all former Aetna Inc.

Dow Finishes Up for Seventh Straight Session Amid Conflicting Trade Signals

Dow Finishes Up for Seventh Straight Session Amid Conflicting Trade Signals

The Dow finished up for the seventh straight day Thursday despite conflicting signals on an interim deal with China that would delay tariffs, while the European Central Bank cut its main deposit rate.

Trading Strategies: A Lookahead to the Fed, Stocks to Watch and CVS

Trading Strategies: A Lookahead to the Fed, Stocks to Watch and CVS

Real Money contributor Stephen Guilfoyle breaks down what to watch from the Fed and stocks he's watching.

CEOs Urge Senate to Take Action on Mass Shootings, Gun Violence

CEOs Urge Senate to Take Action on Mass Shootings, Gun Violence

A letter signed by nearly four dozen CEOs is urging the Senate to take action to prevent and reduce mass shootings and gun violence.

SmileDirectClub Begins Trading 10% Below IPO Pricing

SmileDirectClub Begins Trading 10% Below IPO Pricing

SmileDirectClub opens trading 10% below the $23 a share pricing of its initial public offering.

Google Photos And CVS Pharmacy Team Up To Offer Same-Day Printing At More Than 7,400 Locations Nationwide

Google Photos And CVS Pharmacy Team Up To Offer Same-Day Printing At More Than 7,400 Locations Nationwide

Google Photos Same Day Prints at CVS Pharmacy Enabled by Kodak Moments Technology

SmileDirectClub, Caterpillar, and Walgreens - Midday Wrap Up

SmileDirectClub, Caterpillar, and Walgreens - Midday Wrap Up

SmileDirectClub's IPO fell flat, though the company still raised $1.3 billion.

With CVS, Bulls Still Have Their Work Cut Out for Them

With CVS, Bulls Still Have Their Work Cut Out for Them

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape

CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape

Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.

CVS Shares Gain as Deutsche Bank Starts Coverage of 'Top Pick' With Buy Rating

CVS Shares Gain as Deutsche Bank Starts Coverage of 'Top Pick' With Buy Rating

Analysts at Deutsche Bank call the company its 'top pick' in the managed care, drug supply and beneficiary technology space.

Video: Jim's Daily Rundown for Thursday

Jim discusses the latest trade news, CVS Health, and more!

SmileDirectClub's Initial Public Offering Priced at $23 a Share

SmileDirectClub's Initial Public Offering Priced at $23 a Share

Shares of teeth-straightening provider SmileDirectClub are priced at $23 a share. The stock will begin trading Thursday.

Something to Smile About? SmileDirectClub's IPO

Something to Smile About? SmileDirectClub's IPO

Whether investors have something to smile about when SmileDirectClub kicks off trading at $23 a share remains to be seen, but market-watchers will be watching the teeth-straightening company's IPO carefully on Thursday.

CVS Health Continues to Move Higher - New Stop Recommendation

CVS Health Continues to Move Higher - New Stop Recommendation

CVS continues to move in the right direction for the bulls.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARCB, CVS, GTN.A, IRM, MSCI, PCTI, SFL Downgrades: GDEN, GTS Initiations: EDNT, HYRE, ITRM Read on to get TheStreet Quant Ratings' detailed report:

Aetna Voices Of Health Competition Kicks Off Today

Aetna Voices Of Health Competition Kicks Off Today

HARTFORD, Conn., Sept.

Weekly Roundup

Stocks fell on manufacturing worries, but snapped back by the end of the week on renewed hopes for easing U.S.- China trade tensions.

Video: Jim's Daily Rundown for Friday

Jim and Zev discuss UnitedHealth Group, Palo Alto Networks, Salesforce.com, the insider selling in Microsoft, and much more!

CVS Poaches Fitbit Exec to Lead Consumer Health Efforts: Report

CVS Poaches Fitbit Exec to Lead Consumer Health Efforts: Report

Adam Pellegrini is leaving Fitbit to lead consumer health efforts at CVS, CNBC reported on Friday.

The Charts of CVS Health Are Coming Out of Rehab

The Charts of CVS Health Are Coming Out of Rehab

Let's check out the charts.

Video: Jim's Daily Rundown for Thursday

Jim discusses his interview with Palo Alto Networks CEO Nikesh Arora, the CVS Health-Aetna merger settlement approval, Goldman Sachs and the Apple card, Novartis and more!

SHAREHOLDER ALERT - CVS Health Corporation (CVS) Bronstein, Gewirtz & Grossman, LLC Announces Class Action And Lead Plaintiff Deadline: October 14, 2019

SHAREHOLDER ALERT - CVS Health Corporation (CVS) Bronstein, Gewirtz & Grossman, LLC Announces Class Action And Lead Plaintiff Deadline: October 14, 2019

NEW YORK, Sept. 5, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against  CVS Health Corporation ("CVS" or the "Company") (NYSE: CVS) and certain of its...

CVS-Aetna Gets Approval From Federal Courts

Removal of this additional overhang should facilitate a shift in money flow back to CVS and make the stock far more appreciated.

Real Money Post-Industrial Average Holds Own in Turbulent August

Real Money Post-Industrial Average Holds Own in Turbulent August

Gains in Amgen, CVS, and others helped offset declines in other stocks, as the RMPIA rose over the last two months to 0.6%, handily beating all the major domestic stock market averages.

TheStreet Quant Rating: B (Buy)